Summary of Significant Accounting Policies - Contingent Consideration (Details) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | 141 Months Ended | ||
|---|---|---|---|---|---|
Sep. 30, 2026 |
Sep. 30, 2025 |
Sep. 30, 2026 |
Sep. 30, 2025 |
Sep. 30, 2026 |
|
| Business Combination, Contingent Consideration [Line Items] | |||||
| Change in the estimated fair value of acquisition-related contingent consideration | $ 0 | $ 376 | $ (22,480) | $ 1,587 | |
| Sherlock Biosciences | |||||
| Business Combination, Contingent Consideration [Line Items] | |||||
| Beginning balance | 27,713 | ||||
| Additions | 0 | ||||
| Change in the estimated fair value of acquisition-related contingent consideration | (22,480) | $ (17,900) | |||
| Ending balance | $ 5,233 | $ 5,233 | $ 5,233 | ||
| X | ||||||||||
- Definition Business Combination, Contingent Consideration, Change in Contingent Consideration, Liability, Additions No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of increase (decrease) in value of liability in contingent consideration arrangement in business combination, including, but not limited to, difference arising upon settlement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of liability recognized arising from contingent consideration in a business combination. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|